Saturday, April 27, 2013

$15,000 Annual Fee for Compounding Manufacturers Could Net FDA $45 Million for Inspections


“No Compounding Allowed” Drugs Would Be Established Under Senate Draft Bill

Word Count: 1080 / Article # 14130426008 / Posted: April 26 2013 6:55 PM


Executive Summary

A $15,000 annual establishment fee for “compounding manufacturers” could net FDA $45 million for inspecting those compounding sites.
Subscription required here


No comments: